X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Abbott India with FDC LTD. - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs FDC LTD. - Comparison Results

ABBOTT INDIA    Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA FDC LTD. ABBOTT INDIA/
FDC LTD.
 
P/E (TTM) x 33.0 17.3 190.8% View Chart
P/BV x 8.2 3.6 228.6% View Chart
Dividend Yield % 0.8 1.3 62.1%  

Financials

 ABBOTT INDIA   FDC LTD.
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-16
FDC LTD.
Mar-14
ABBOTT INDIA/
FDC LTD.
5-Yr Chart
Click to enlarge
High Rs6,015144 4,191.6%   
Low Rs3,70779 4,692.4%   
Sales per share (Unadj.) Rs1,236.947.6 2,600.4%  
Earnings per share (Unadj.) Rs122.27.6 1,605.7%  
Cash flow per share (Unadj.) Rs129.09.0 1,431.5%  
Dividends per share (Unadj.) Rs35.002.25 1,555.6%  
Dividend yield (eoy) %0.72.0 35.6%  
Book value per share (Unadj.) Rs521.247.5 1,096.6%  
Shares outstanding (eoy) m21.25177.83 11.9%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x3.92.3 168.0%   
Avg P/E ratio x39.814.6 272.1%  
P/CF ratio (eoy) x37.712.3 305.2%  
Price / Book Value ratio x9.32.3 398.5%  
Dividend payout %28.629.6 96.9%   
Avg Mkt Cap Rs m103,29619,784 522.1%   
No. of employees `0003.0NA-   
Total wages/salary Rs m3,3701,221 276.1%   
Avg. sales/employee Rs Th8,891.8NM-  
Avg. wages/employee Rs Th1,140.0NM-  
Avg. net profit/employee Rs Th878.3NM-  
INCOME DATA
Net Sales Rs m26,2848,459 310.7%  
Other income Rs m504394 128.2%   
Total revenues Rs m26,7898,852 302.6%   
Gross profit Rs m3,6652,070 177.1%  
Depreciation Rs m144249 58.0%   
Interest Rs m831 26.1%   
Profit before tax Rs m4,0172,184 184.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-225 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,421606 234.7%   
Profit after tax Rs m2,5961,353 191.9%  
Gross profit margin %13.924.5 57.0%  
Effective tax rate %35.427.7 127.6%   
Net profit margin %9.916.0 61.7%  
BALANCE SHEET DATA
Current assets Rs m14,4464,355 331.7%   
Current liabilities Rs m4,7251,792 263.7%   
Net working cap to sales %37.030.3 122.0%  
Current ratio x3.12.4 125.8%  
Inventory Days Days5144 115.6%  
Debtors Days Days2025 79.3%  
Net fixed assets Rs m1,1133,025 36.8%   
Share capital Rs m213179 119.0%   
"Free" reserves Rs m10,8088,243 131.1%   
Net worth Rs m11,0768,453 131.0%   
Long term debt Rs m011 0.0%   
Total assets Rs m16,24110,557 153.8%  
Interest coverage x497.071.4 695.9%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.60.8 202.0%   
Return on assets %16.013.1 122.3%  
Return on equity %23.416.0 146.4%  
Return on capital %36.323.5 154.6%  
Exports to sales %0.613.3 4.6%   
Imports to sales %12.63.3 378.1%   
Exports (fob) Rs m1621,126 14.4%   
Imports (cif) Rs m3,322283 1,174.9%   
Fx inflow Rs m2681,146 23.4%   
Fx outflow Rs m3,927355 1,105.4%   
Net fx Rs m-3,659791 -462.7%   
CASH FLOW
From Operations Rs m2,5141,485 169.3%  
From Investments Rs m-800-620 129.1%  
From Financial Activity Rs m-803-753 106.7%  
Net Cashflow Rs m912113 808.4%  

Share Holding

Indian Promoters % 0.0 68.9 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 4.7 168.1%  
FIIs % 0.1 7.5 1.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 19.0 90.0%  
Shareholders   18,270 23,730 77.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   ALEMBIC PHARMA  BIOCON LTD  UNICHEM LAB  ALKEM LABORATORIES  AJANTA PHARMA  

Compare ABBOTT INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Dr Reddy's & Lupin Surge over 2%(Closing)

Indian share markets continued to trade just above the dotted line in the afternoon session in a lackluster day of trading. At the closing bell, the BSE Sensex closed higher by 33 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Aug 22, 2017 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 5-YR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS